Position in ABBV
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$40,268,187
+$6,318,652 QoQ
Shares Held
160,023
+2.5% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.70%
of 13F equity value
Holder Rank
#419
of 4,153 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Derivatives in ABBV
reported options exposure · as of Jun 30, 2026CallValue
$5,963,868
CallShares
23,700
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Concurrent Investment Advisors, LLC holds $273,585,885 across 14 Drug Manufacturers - General names. ABBV ranks #3 (14.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
232,761 | $59,114,311 | |
| 2 | LLY |
ELI LILLY & Co
|
46,836 | $56,176,507 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
160,023 | $40,268,187 | |
| 4 | MRK |
Merck & Co., Inc.
|
280,871 | $36,091,923 | |
| 5 | PFE |
Pfizer Inc
|
891,770 | $21,473,821 | |
| 6 | AMGN |
Amgen Inc
|
51,650 | $18,703,497 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
266,252 | $15,341,440 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
81,664 | $10,317,429 |
All Filings in ABBV
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $40,268,187 | 160,023 | Shares | Sole | 2026-07-27 | |
| 2026-06-30 | $5,963,868 | 23,700 | Call | Sole | 2026-07-27 | |
| 2026-03-31 | $5,154,513 | 23,700 | Call | Sole | 2026-04-21 | |
| 2026-03-31 | $33,949,535 | 156,097 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $35,994,258 | 157,531 | Shares | Sole | 2026-01-29 | |
| 2025-12-31 | $11,287,406 | 49,400 | Call | Sole | 2026-01-29 | |
| 2025-09-30 | $5,487,498 | 23,700 | Call | Sole | 2025-10-27 | |
| 2025-09-30 | $25,957,717 | 112,109 | Shares | Sole | 2025-10-27 | |
| 2025-06-30 | $18,916,162 | 101,908 | Shares | Sole | 2025-07-25 | |
| 2025-06-30 | $1,911,886 | 10,300 | Call | Sole | 2025-07-25 | |
| 2025-03-31 | $19,647,318 | 93,773 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $13,169,880 | 74,113 | Shares | Sole | 2025-02-03 | |
| 2024-09-30 | $13,652,384 | 69,133 | Shares | Sole | 2024-10-30 | |
| 2024-06-30 | $11,556,846 | 67,379 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $8,887,026 | 48,803 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $6,985,427 | 45,076 | Shares | Sole | 2024-04-15 | |
| No filing history on record for this holder in this stock. | ||||||